Literature DB >> 20865470

Infectious complications in neutropenic cancer patients.

Francesco Menichetti1.   

Abstract

Cancer patients are at risk of infectious complications due to neutropenia following chemotherapy or early post-HSCT (Hemato Stem Cell Transplantation). The first episode of fever during recent onset neutropenia is caused mostly by bacteria, while subsequent episodes are mainly fungal in nature. Proper management of infectious complications in neutropenic cancer patients requires classification into the appropriate risk category and knowledge of the local epidemiology of infections, of the causative organisms and their resistance phenotype.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20865470     DOI： 10.1007/s11739-010-0456-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


  8 in total

Review 1.  Fever in immunocompromised patients.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.

Authors:  Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Leonard Leibovici
Journal:  Ann Intern Med       Date:  2005-06-21       Impact factor: 25.391

3.  Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Authors:  Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Hermann Einsele; Werner J Heinz; Meinolf Karthaus; Stefan W Krause; William Krüger; Georg Maschmeyer; Olaf Penack; Jörg Ritter; Markus Ruhnke; Michael Sandherr; Michal Sieniawski; Jörg-Janne Vehreschild; Hans-Heinrich Wolf; Andrew J Ullmann
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

4.  Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.

Authors:  Johan Maertens; Koen Theunissen; Gregor Verhoef; Johnny Verschakelen; Katrien Lagrou; Eric Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Journal:  Clin Infect Dis       Date:  2005-09-29       Impact factor: 9.079

5.  Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.

Authors:  Michael Cullen; Neil Steven; Lucinda Billingham; Claire Gaunt; Mark Hastings; Peter Simmonds; Nicholas Stuart; Daniel Rea; Mark Bower; Indrajit Fernando; Robert Huddart; Simon Gollins; Andrew Stanley
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

6.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.

Authors:  Giampaolo Bucaneve; Alessandra Micozzi; Francesco Menichetti; Pietro Martino; M Stella Dionisi; Giovanni Martinelli; Bernardino Allione; Domenico D'Antonio; Maurizio Buelli; A Maria Nosari; Daniela Cilloni; Eliana Zuffa; Renato Cantaffa; Giorgina Specchia; Sergio Amadori; Francesco Fabbiano; Giorgio Lambertenghi Deliliers; Francesco Lauria; Robin Foà; Albano Del Favero
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

7.  Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors:  T J Walsh; R W Finberg; C Arndt; J Hiemenz; C Schwartz; D Bodensteiner; P Pappas; N Seibel; R N Greenberg; S Dummer; M Schuster; J S Holcenberg
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

8.  Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

Authors:  Catherine Cordonnier; Cécile Pautas; Sébastien Maury; Anne Vekhoff; Hassan Farhat; Felipe Suarez; Nathalie Dhédin; Francoise Isnard; Lionel Ades; Frédérique Kuhnowski; Françoise Foulet; Mathieu Kuentz; Patrick Maison; Stéphane Bretagne; Michaël Schwarzinger
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079
  8 in total
  3 in total

1.  Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies?

Authors:  Reza Berahmat; Mahmoud Mahami-Oskouei; Azim Rezamand; Adel Spotin; Nayyereh Aminisani; Roghayeh Ghoyounchi; Solmaz Madadi
Journal:  Parasitol Res       Date:  2017-07-20       Impact factor: 2.289

2.  Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia.

Authors:  Youn-Jung Kim; Sung Min Jung; Jihoon Kang; Seung Mok Ryoo; Chang Hwan Sohn; Dong-Woo Seo; Kyoung Soo Lim; Jin Won Huh; Sung-Han Kim; Won Young Kim
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

Review 3.  Epidemiology of infections in cancer patients.

Authors:  Teresa R Zembower
Journal:  Cancer Treat Res       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.